Frontlight ResearchEarly access
Trial site
Rocky Mountain Cancer Centers LLP
- 9running trials
- 1closed trial
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Colorectal cancer2 trials
- Metastatic breast cancer2 trials
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Kidney cancer1 trial
- Melanoma1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 36 trials
- Phase 1/22 trials
- Phase 21 trial
- Phase 2/31 trial
- Status
- Recruiting6 trials
- Active, not recruiting3 trials
- Completed1 trial
- Lead sponsor
- Pfizer6 trials
- Seagen, a wholly owned subsidiary of Pfizer3 trials
- Revolution Medicines, Inc.1 trial
Running trials
Recruiting
Recruiting
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Active, not recruiting
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Kidney cancer1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026